サンプル依頼リスト カート
  • English
  • Korean
表紙：エピジェネティクスの世界市場：市場規模、シェア、動向分析、機会、予測（2019年～2030年）
市場調査レポート
商品コード
1410997

エピジェネティクスの世界市場：市場規模、シェア、動向分析、機会、予測（2019年～2030年）

Epigenetics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Technology ; By Application ; By Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 400 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
エピジェネティクスの世界市場：市場規模、シェア、動向分析、機会、予測（2019年～2030年）
出版日: 2024年01月16日
発行: Blueweave Consulting
ページ情報: 英文 400 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のエピジェネティクスの市場規模はCAGR 15.2%で2倍以上となり、2030年までには54億7,000万米ドルに達すると予測されます。

世界のエピジェネティクス市場は、個別化医療の範囲拡大とともに、増加するがんの有病率の治療と管理、ヘルスケア部門における研究開発活動の強化にますます焦点が当てられているため、活況を呈しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consultingは、最近の調査で、2023年の世界のエピジェネティクスの市場規模を23億4,000万米ドルと推定しました。2024年から2030年までの予測期間において、BlueWeaveは世界のエピジェネティクス市場規模がCAGR 15.20%で拡大し、2030年までには54億7,000万米ドルに達すると予測しています。がんや心血管疾患を含む慢性疾患の有病率の増加や、医薬品の研究開発の増加は、エピジェネティクスの世界市場の重要な促進要因となっています。さらに、予測期間を通じて、標的医薬品の開発とカスタマイズ医療への重点の高まりは、世界のエピジェネティクス市場のプレーヤーに大きな機会を提供することが期待されています。

本レポートの詳細な分析により、成長の可能性、今後の動向、世界のエピジェネティクス市場に関する情報を提供します。また、総市場規模の予測を促進する要因にも焦点を当てています。当レポートは、世界のエピジェネティクス市場における最近の技術動向や、意思決定者が健全な戦略的意思決定を行うための業界洞察を提供することを約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界のエピジェネティクス市場に関する洞察

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 慢性疾患の有病率の上昇
      • エピジェネティクス技術の進歩
      • エピジェネティクス調査への投資の増加
    • 抑制要因
      • データプライバシーに関する懸念
      • エピジェネティクス技術のコスト
    • 機会
      • 個別化医療の開発
      • 新たな用途への展開
    • 課題
      • 規制のハードル
      • 標準化の欠如
  • 技術の進歩/最近の開発
  • 消費者の行動と洞察
  • 規制の枠組み
  • ポーターのファイブフォース分析

第4章 世界のエピジェネティクス市場概要

  • 市場規模と予測、2019年～2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
      • 試薬
      • キット
      • チップシーケンスキット
      • 全ゲノム増幅キット
      • 亜硫酸水素塩変換キット
      • RNAシーケンスキット
      • その他
      • 機器
      • 酵素
      • サービス
    • テクノロジー別
      • DNAメチル化
      • ヒストンのメチル化
      • ヒストンのアセチル化
      • 大きな非コーディング RNA
      • マイクロRNA修飾
      • クロマチンの構造
    • 用途別
      • 腫瘍学
      • 固形腫瘍
      • 液体腫瘍
      • 非腫瘍学
      • 炎症性疾患
      • 代謝性疾患
      • 感染症
      • 心血管疾患
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋（APAC）
      • ラテンアメリカ（LATAM）
      • 中東・アフリカ（MEA）

第5章 北米のエピジェネティクス市場

  • 市場規模と予測、2019年～2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • テクノロジー別
    • 用途別
    • 国別
      • 米国
      • カナダ

第6章 欧州のエピジェネティクス市場

  • 市場規模と予測、2019年～2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • テクノロジー別
    • 用途別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • ベルギー
      • ロシア
      • オランダ
      • その他欧州

第7章 アジア太平洋のエピジェネティクス市場

  • 市場規模と予測、2019年～2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • テクノロジー別
    • 用途別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリアとニュージーランド
      • インドネシア
      • マレーシア
      • シンガポール
      • ベトナム
      • その他アジア太平洋

第8章 ラテンアメリカのエピジェネティクス市場

  • 市場規模と予測、2019年～2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • テクノロジー別
    • 用途別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • ペルー
      • その他ラテンアメリカ

第9章 中東・アフリカのエピジェネティクス市場

  • 市場規模と予測、2019年～2030年
    • 金額別
  • 市場シェアと予測
    • 製品別
    • テクノロジー別
    • 用途別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • カタール
      • クウェート
      • 南アフリカ
      • ナイジェリア
      • アルジェリア
      • その他中東・アフリカ

第10章 競合情勢

  • 主要企業とその製品のリスト
  • 世界のエピジェネティクス市場シェア分析、2023年
  • 経営パラメータによる競合ベンチマーキング
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 地政学的緊張の高まりが世界のエピジェネティクス市場に与える影響

第12章 企業プロファイル（会社概要、財務マトリクス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

  • Qiagen
  • Thermo Fisher Scientific
  • Illumina
  • Agilent Technologies
  • Zymo Research
  • Clontech
  • New England Biolabs（NEB）
  • EpigenTek Group Inc.
  • Active Motif
  • Diagenode
  • その他の主要企業

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC24035

Global Epigenetics Market Size More Than Doubles at Robust CAGR of 15.2%, to Reach USD 5.47 Billion by 2030.

Global Epigenetics Market is flourishing because of and increasing focus on the treatment and management of rising prevalence of cancer and intensifying R&D activities in the healthcare sector, along with expanding scope of personalized medicine.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Epigenetics Market size at USD 2.34 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Epigenetics Market size to expand at a CAGR of 15.20% reaching a value of USD 5.47 billion by 2030. The growing prevalence of chronic illnesses, including cancer and cardiovascular diseases, as well as an increase in pharmaceutical research and development are significant driving factors for the Global Epigenetics Market. Moreover, throughout the projected period, the development of targeted medicines and a growing emphasis on customized medicine are expected to provide substantial opportunities for players in the Global Epigenetic Market.

Opportunity: Advanced research and development activities

With the rising prevalence of various chronic diseases, various pharmaceutical and biotechnology companies are increasing their investments in R&D programs to make advancements in epigenetics and expand its application in non-oncology segments as well. A recent study published in the scientific journal Nature explores the epigenetic changes in cancer progression as well as identifies the cellular pathways of these genes that may potentially prove crucial in developing strategies for maximizing the therapeutic benefits while minimizing the side effects. Positive outcomes from research and development activities are anticipated to provide lucrative growth opportunities for companies in the Global Epigenetics Market over the forecast period.

Impact of Escalating Geopolitical Tensions on Global Epigenetics Market

The escalating geopolitical tensions hampered the growth of the global epigenetics market. For instance, Ukraine is one of the leading healthcare providers and engages in extensive research and development activities. However, after Russia attacked Ukraine in February 2022, the healthcare and clinical infrastructure of Ukraine were impacted. Patients from abroad as well as those within Ukraine experienced difficulties accessing healthcare resources due to the regional unrest in the country, especially in the Kyiv region. Research collaborations and international partnerships in clinical research may be put under pressure after the situation in Ukraine, which might impede advancements in the sector. Essentially, these geopolitical tensions highlight the necessity for strategic adaptability and resilience in navigating these challenging conditions by introducing uncertainties and obstacles across all aspects of the epigenetics business.

Global Epigenetics Market

Segmental Coverage

Global Epigenetics Market - By Technology

Based on technology, the Global Epigenetics Market is segmented into DNA Methylation, Histone Methylation, Histone Acetylation, Large Non-Coding RNA, MicroRNA Modification, and Chromatin Structures. DNA methylation technology holds the largest share in the Global Epigenetics Market. According to a report published in The Lancet, with tissue-specific variations, methylation may be utilized in a basic cell-free circulating-DNA blood test to identify cell death and track several prevalent diseases. Additionally, it demonstrates the enormous potential for disease diagnosis, customized treatment, and prevention.

Global Epigenetics Market - By Region

The in-depth research report on the Global Epigenetics Market covers the market in a major number of countries across five regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Epigenetics Market. Accessible healthcare services, along with advanced medical infrastructure, act as a major driving factor for market growth in the region. Moreover, extensive research and development activities surrounding epigenetics, owing to the high concentration of leading pharmaceutical companies and favorable government support, contribute to the epigenetics market growth in North America.

Competitive Landscape

Major players operating in the Global Epigenetics Market include: Qiagen, Thermo Fisher Scientific, Illumina, Agilent Technologies, Zymo Research, Clontech, New England Biolabs (NEB), EpigenTek Group Inc., Active Motif, and Diagenode. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Epigenetics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Epigenetics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Epigenetics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising Prevalence of Chronic Diseases
      • 3.2.1.2. Advances in Epigenetic Technologies
      • 3.2.1.3. Increasing Investment in Epigenetics Research
    • 3.2.2. Restraints
      • 3.2.2.1. Data Privacy Concerns
      • 3.2.2.2. Cost of Epigenetic Technologies
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of Personalized Medicine
      • 3.2.3.2. Expansion into New Applications
    • 3.2.4. Challenges
      • 3.2.4.1. Regulatory Hurdles
      • 3.2.4.2. Lack of Standardization
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Consumer Behavior and Insights
  • 3.5. Regulatory Framework
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of New Entrants
    • 3.6.4. Threat of Substitutes
    • 3.6.5. Intensity of Rivalry

4. Global Epigenetics Market Overview

  • 4.1. Market Size & Forecast, 2019-2030
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Reagents
      • 4.2.1.2. Kits
      • 4.2.1.2.1. Chip Sequencing Kit
      • 4.2.1.2.2. Whole Genomic Amplification Kit
      • 4.2.1.2.3. Bisulfite Conversion Kit
      • 4.2.1.2.4. RNA Sequencing Kit
      • 4.2.1.2.5. Others
      • 4.2.1.3. Instruments
      • 4.2.1.4. Enzymes
      • 4.2.1.5. Services
    • 4.2.2. By Technology
      • 4.2.2.1. DNA Methylation
      • 4.2.2.2. Histone Methylation
      • 4.2.2.3. Histone Acetylation
      • 4.2.2.4. Large Non - Coding RNA
      • 4.2.2.5. MicroRNA Modification
      • 4.2.2.6. Chromatin Structures
    • 4.2.3. By Application
      • 4.2.3.1. Oncology
      • 4.2.3.1.1. Solid Tumors
      • 4.2.3.1.2. Liquid Tumors
      • 4.2.3.2. Non - Oncology
      • 4.2.3.2.1. Inflammatory Diseases
      • 4.2.3.2.2. Metabolic Diseases
      • 4.2.3.2.3. Infectious Diseases
      • 4.2.3.2.4. Cardiovascular Diseases
      • 4.2.3.2.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Epigenetics Market

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By Application
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Product
      • 5.2.4.1.2. By Technology
      • 5.2.4.1.3. By Application
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Product
      • 5.2.4.2.2. By Technology
      • 5.2.4.2.3. By Application

6. Europe Epigenetics Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Product
      • 6.2.4.1.2. By Technology
      • 6.2.4.1.3. By Application
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Product
      • 6.2.4.2.2. By Technology
      • 6.2.4.2.3. By Application
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Product
      • 6.2.4.3.2. By Technology
      • 6.2.4.3.3. By Application
      • 6.2.4.4. France
      • 6.2.4.4.1. By Product
      • 6.2.4.4.2. By Technology
      • 6.2.4.4.3. By Application
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Product
      • 6.2.4.5.2. By Technology
      • 6.2.4.5.3. By Application
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Product
      • 6.2.4.6.2. By Technology
      • 6.2.4.6.3. By Application
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Product
      • 6.2.4.7.2. By Technology
      • 6.2.4.7.3. By Application
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Product
      • 6.2.4.8.2. By Technology
      • 6.2.4.8.3. By Application
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Product
      • 6.2.4.9.2. By Technology
      • 6.2.4.9.3. By Application

7. Asia Pacific Epigenetics Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Product
      • 7.2.4.1.2. By Technology
      • 7.2.4.1.3. By Application
      • 7.2.4.2. India
      • 7.2.4.2.1. By Product
      • 7.2.4.2.2. By Technology
      • 7.2.4.2.3. By Application
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Product
      • 7.2.4.3.2. By Technology
      • 7.2.4.3.3. By Application
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Product
      • 7.2.4.4.2. By Technology
      • 7.2.4.4.3. By Application
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Product
      • 7.2.4.5.2. By Technology
      • 7.2.4.5.3. By Application
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Product
      • 7.2.4.6.2. By Technology
      • 7.2.4.6.3. By Application
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Product
      • 7.2.4.7.2. By Technology
      • 7.2.4.7.3. By Application
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Product
      • 7.2.4.8.2. By Technology
      • 7.2.4.8.3. By Application
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Product
      • 7.2.4.9.2. By Technology
      • 7.2.4.9.3. By Application
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Product
      • 7.2.4.10.2. By Technology
      • 7.2.4.10.3. By Application

8. Latin America Epigenetics Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Product
      • 8.2.4.1.2. By Technology
      • 8.2.4.1.3. By Application
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Product
      • 8.2.4.2.2. By Technology
      • 8.2.4.2.3. By Application
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Product
      • 8.2.4.3.2. By Technology
      • 8.2.4.3.3. By Application
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Product
      • 8.2.4.4.2. By Technology
      • 8.2.4.4.3. By Application
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Product
      • 8.2.4.5.2. By Technology
      • 8.2.4.5.3. By Application

9. Middle East & Africa Epigenetics Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Product
      • 9.2.4.1.2. By Technology
      • 9.2.4.1.3. By Application
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Product
      • 9.2.4.2.2. By Technology
      • 9.2.4.2.3. By Application
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Product
      • 9.2.4.3.2. By Technology
      • 9.2.4.3.3. By Application
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Product
      • 9.2.4.4.2. By Technology
      • 9.2.4.4.3. By Application
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Product
      • 9.2.4.5.2. By Technology
      • 9.2.4.5.3. By Application
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Product
      • 9.2.4.6.2. By Technology
      • 9.2.4.6.3. By Application
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Product
      • 9.2.4.7.2. By Technology
      • 9.2.4.7.3. By Application
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Product
      • 9.2.4.8.2. By Technology
      • 9.2.4.8.3. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Epigenetics Market Share Analysis, 2023
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Escalating Geopolitical Tensions on Global Epigenetics Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Qiagen
  • 12.2. Thermo Fisher Scientific
  • 12.3. Illumina
  • 12.4. Agilent Technologies
  • 12.5. Zymo Research
  • 12.6. Clontech
  • 12.7. New England Biolabs (NEB)
  • 12.8. EpigenTek Group Inc.
  • 12.9. Active Motif
  • 12.10. Diagenode
  • 12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations